TMCnet News
Evolution Research Group and Invicro LLC Partner to Offer Clinical Research and Advanced Data Analysis and Management ServicesToday, Evolution Research Group (ERG) and Invicro LLC, a Konica Minolta (News - Alert) Company announced a strategic partnership to offer biotech and pharma sponsors early to late phase clinical research trials, advanced data analysis and project management services. ERG is a leading independent clinical research site company specializing in number of therapeutic areas including Psychiatry, Neurology, Alzheimer's Disease, NASH, Diabetes and Tobacco among others. Invicro is a global provider of imaging biomarkers, core lab services, advanced analytics and software solutions for clinical research. This partnership will offer pharmaceutical sponsors a seamless process for inpatient and outpatient clinical research trials backed by unparallel support including centralized recruiting, operational excellence, clinical consultation, advanced data analysis and project management support. "We are pleased to partner with such an industry leader in clinical research as ERG," stated Mr. Roughan Sheedy, Chief Commercial Officer of Invicro. "We believe this alliance will allow our companies to jointly offer efficient and flexible clinical research studies that will deliver effective results to support our pharma sponsors' drug development and clinical research projects." ERG has completed over 5,000 clinical trials leveraging a broad network of state-of-the-art ERG portfolio and affiliate sites throughout the United States, supporting both early and late-phase clinical trials. Invicro has processed nearly 25-million (DICOM) images and defined over 6-million unique quantification data points. The combined strength of ERG and Invicro, will allow pharma and biotech customers to uncover answers to support more timely and accurate decision-making throughout their clinical research trials. "Invicro's innovation and expertise in the area of medical imaging biomarkers, advanced analytics and software is unprecedented," noted Dr. Davide Molho, President and CEO of ERG. "We look forward to this collaboration to support the research community and their life-changing research projects across all therapeutic areas." The partnership between ERG and Invicro is effective immediately.
About Evolution Research Group
The ERG team, which consists of over 400 employees, owns and operates specialty inpatient and outpatient research units across the country, conducting phase I-IV clinical research trials. Additionally, ERG manages a network of affiliated clinical research sites and has access to over 32 million potential patients to support sponsors conducting research. Learn more about ERG by visiting www.ergclinical.com
About Invicro
As part of the Konica Minolta precision medicine organization and with their sister company Ambry Genetics, Invicro develops and leverages the latest approaches in quantitative biomarkers including imaging, quantitative pathology and genomics. For more information, visit www.invicro.com.
About Konica Minolta
View source version on businesswire.com: https://www.businesswire.com/news/home/20191118005523/en/ |